110 related articles for article (PubMed ID: 3871663)
1. Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2.
Ramos OF; Masucci MG; Klein E
Cell Immunol; 1985 Mar; 91(1):178-92. PubMed ID: 3871663
[TBL] [Abstract][Full Text] [Related]
2. The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytes.
Ramos OF; Masucci MG; Bejarano MT; Klein E
Immunobiology; 1983 Dec; 165(5):403-14. PubMed ID: 6607208
[TBL] [Abstract][Full Text] [Related]
3. Phorbol esters inhibit the functional activation of cytotoxic precursors in mixed lymphocyte cultures.
Masucci MG; Torsteinsdottir S; Pear W; Carstensen A; Klein E
J Immunol; 1984 Oct; 133(4):1755-62. PubMed ID: 6236256
[TBL] [Abstract][Full Text] [Related]
4. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
Trinchieri G; O'Brien T; Shade M; Perussia B
J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
[TBL] [Abstract][Full Text] [Related]
5. Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compounds.
Ramos OF; Masucci MG; Klein E
Cancer Res; 1984 May; 44(5):1857-62. PubMed ID: 6201264
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester-induced lymphocyte adherence: selective action on NK cells.
Argov S; Hebdon M; Cuatrecasas P; Koren HS
J Immunol; 1985 Apr; 134(4):2215-22. PubMed ID: 3855930
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester-inactivation of cloned cytotoxic T lymphocytes: restoration of lytic activity by interleukin 2 and induction of interferon production are separable events.
Finke JH; Yen-Lieberman B; Scott JW; Proffitt MR; Orosz CG
Lymphokine Res; 1985; 4(4):299-308. PubMed ID: 3930891
[TBL] [Abstract][Full Text] [Related]
8. Phorbol-ester stimulated lysis of weak and nonspecific target cells by cytotoxic T lymphocytes.
Russell JH
J Immunol; 1986 Jan; 136(1):23-7. PubMed ID: 2415619
[TBL] [Abstract][Full Text] [Related]
9. Phorbol esters inactivate the lytic apparatus of cytotoxic T lymphocytes.
Russell JH
J Immunol; 1984 Aug; 133(2):907-12. PubMed ID: 6610713
[TBL] [Abstract][Full Text] [Related]
10. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
Stanková J; Rola-Pleszczynski M
J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones.
Bensussan A; Tourvieille B; Chen LK; Dausset J; Sasportes M
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6642-6. PubMed ID: 3876559
[TBL] [Abstract][Full Text] [Related]
12. K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms.
Shanahan F; Brogan MD; Newman W; Targan SR
J Immunol; 1986 Jul; 137(2):723-6. PubMed ID: 3487579
[TBL] [Abstract][Full Text] [Related]
13. Phorbol 12,13-dibutyrate (P(Bu)2)-treated human blood mononuclear cells bind to each other.
Patarroyo M; Biberfeld P; Klein E; Klein G
Cell Immunol; 1983 Jan; 75(1):144-53. PubMed ID: 6402310
[TBL] [Abstract][Full Text] [Related]
14. K562 cells induced to differentiate by phorbol ester tumor promotors resist NK lysis.
Dokhelar MC; Garson D; Wakasugi H; Tabilio A; Testa U; Vainchenker W; Tursz T
Cell Immunol; 1984 Sep; 87(2):389-99. PubMed ID: 6205768
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers.
Haskard D; Cavender D; Ziff M
J Immunol; 1986 Sep; 137(5):1429-34. PubMed ID: 3091681
[TBL] [Abstract][Full Text] [Related]
16. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
Owen-Schaub LB; Gutterman JU; Grimm EA
Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
[TBL] [Abstract][Full Text] [Related]
17. Phorbol ester mediates reversible reduction of cloned T lymphocyte cytolysis.
Orosz CG; Roopenian DC; Bach FH
J Immunol; 1983 Jun; 130(6):2499-501. PubMed ID: 6602165
[TBL] [Abstract][Full Text] [Related]
18. Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate.
Hara T; Fu SM
J Exp Med; 1985 Apr; 161(4):641-56. PubMed ID: 3920341
[TBL] [Abstract][Full Text] [Related]
19. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
McCrady CW; Li F; Grant AJ; Merchant RE; Carchman RA
Cancer Res; 1988 Feb; 48(3):635-40. PubMed ID: 3257170
[TBL] [Abstract][Full Text] [Related]
20. Phorbol myristate acetate and in vitro T lymphocyte function. III. Selective impairment by PMA of lethal hit delivery by cloned CTL.
Orosz CG; Roopenian DC
Transplantation; 1985 Apr; 39(4):411-8. PubMed ID: 3157247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
